Acta Histochem, Cytochem, 38 (3): 201-208, 2000,
Streptozotocin and Alloxan in Experimental Diabetes: Comparison
of the Two Models in Rats
erg
Islas-Andrade, Ma. Cristina Revilla Monsalve, Jorge Escobedo de la Peit
Ana C Polanco, Miguel Angel Palomino and Alfredo Feria Velasco*
Unidad de Investigacion Médica en Enfermedades Metabsicas, Centro Médico Nacinal Siglo XXI, ILM.S.S. México
Ctyand "Division de Patologia y Bioteenologia Ambiental, CIA TEI, (SEP-CONACYT) Guadalajara, Jalisco, México
Received December 24,1999; accepted May 12, 2000
Diabetic animals have contributed to the
understanding of the causes, consequences
and treatment of diabetes. There are differ
ent ways to induce experimental diabetes,
chemically induced experimental diabetes
has been widely used. Alloxan and strepto-
zotocin are the chemicals most used. A
comparative study of these two agents
was performed in order to determine their
effectiveness. Twenty-seven Sprague-Dawley
male adult rats were intraperitoneally (.p.)
injected with 120 mg/kg BW of alloxan (AL) and
27 with 60 mg/kg BW of streptozotocin (STZ)
Key words:
1. Introdu
Diabetes mellitus is the name given to a multiple
group of disorders with different etiologies. It is charac-
terized by derangement in carbohydrate, protein, and fat
‘metabolism caused by the complete or relative insufficiency
Of insulin secretion and/or insulin action. Experimental
diabetes has the advantage that it allows the analysis of
the biochemical, hormonal and morphological events that
take place not only during the induction of a diabetic state
but also after it has taken place and during its evolution to
a severe insulin deficiency or even death. This strategy has
reat advantages but it has to be considered that none of
the animal models with induced diabetes corresponds ex-
actly to the human Type 2 diabetes mellitus, nonetheless
they provide models to investigate the pathogenic mechan-
isms that lead to hyperglycemia and its consequences [2].
‘There are several techniques for inducing experimen-
tal diabetes which include the chemical destruction, the
Correspondence to: Dr. Sergio Islas Andrade, Unidad de Inves:
tigacién Médica en Enfermedades Metabélicas, Centio Médico
‘Nacional, IMSS, Apartado Postal 13-800, Colonia Nativitas CP
(03500, Mexico City, Mexico,
201
Levels of glucose, insulin, triglycerides and
total cholesterol were determined at differ-
cent times after the i.p. injection. The effect
‘of the two chemicals on the Langerhans’
islets was histochemically demonstrated,
The reversibility of the diabetic state, 20
days after the i.p. injection of AL, was dem-
onstrated by the recovery of insulin levels,
reduction of the glucose and triglycerides
concentration and by positive anti-nsulin
antibodies reaction in the pancres
STZ proved to induce a more stable and
permanent diabetic stat
Experimental diabetes, Streptozotocin, Alloxan
surgical removal of the 3 cell mass or even the pancrea
tectomy, the injury of the ventromedial hypothalamus,
feeding with high-fat and high-sugar diets, malnutrition
‘in utero; high dosages of counter-regulatory hormones,
particularly glucocorticoids and a prolonged exposure t0
hyperinsulinemia [2, 7, 9, 23]. Hormones like adrenaline,
glucagon, glucocorticoids and somatotropin that have an
antagonic effect on insulin, when present in excess as a
consequence of stress, tumors or other metabolic altera-
tions can also provoke hyperglycemia [14].
Different chemical agents are capable of producing
the alterations related to the diabetic condition; two of the
most widely used are alloxan (AL) and streptozotocin
(STZ) (7, 9, 10, 13, 14),
AL became the first diabetogenic chemical agent when
Dunn and Me Letchie accidentally produced isletcell
necrosis in rabbits while researching the nephrotoxicity of
uric acid derivates. In vitro, AL. displays exceptionally
specific inhibitory and cytotoxic effects on 3 cells, other
fslet-cell types being unaffected [7]. However, its
mechanism of action is not well known. Some studies
point to the fact that alloxan’s initial effect is mediated
by a certain interaction at the membrane of 3 cells
resulting in selective necrosis (8, 36]. It has been202 Islas-Andrade et al
reported that it inhibits glucose-stimulated insulin release
{8] and high doses cause j-cell necrosis and a severe
insulin deficiency with ketosis.
‘AL is soluble in water, has a high affinity for the thiol
groups and for Zn** and inhibits the hexokinase and
other enzymes 8]. In certain species, these chemical
characteristics of alloxan are responsible for the
non-appearance of its diabetogenic effect. Thus, it is
possible thatthe interference with the metabolism of that
element may be important in the action ofthe drug [2, 7}
Okamoto er al. studying the mechanism of action of
AL proposed a model in which the fragmentation of the
nuclear DNA of pancreatic j-cells seems to be important
for the induction of diabetes and this fragmentation
is supposed to be the result of the accumulation of
superoxide or hydroxyl radicals (25, 30]. Takasu [34]
demonstrated that alloxan and streptozotocin stimulate
the generation of H.O- which induces DNA fragmentation,
Actually low doses of AL are sill used to induce
experimental diabetes, causing a partial reduction of j-cell
mass that can produce a mildly insulin-deficient state,
without ketosis and also insulin resistance (1, 27, 32).
Tt has also been reported that the sensitivity to this
agent varies with species, strain, sex, age, and nutritional
state [2]
On the other hand, the streptozotocin (STZ) is a
nitrosourea derivative isolated from the mould Sirep-
fomyces griseus. It can induce severe insulin-deficient
diabetes in rats and other rodents, ether when given as
a single large dose (50-100 mg/kg in rats) or as multiple
smaller doses; in the later case, diabetes develops more
eradually and appears to have an autoimmune, rather than
toxic, basis. Diabetes induced by a single intravenous or
intraperitoneal injection of STZ is probably the most
widely used experimental model of insulin-dependent
diabetes mellitus. With a dosage of 50-60 mg/kg, insulin
levels typically fall to 10-30% of normal, leading to
hyperglycemia (20-30mmol/1), polyuria, polydipsia and
weight loss, however severe ketosis does not develop and
the animals can survive for some weeks without insulin
replacement. Higher dosages induce moze profound
insulin deficiency, resulting in spontaneous ketosis and
death if insulin is not given [4] STZ causes j-cell necrosis
and diabetes supervenes within 1-2days with damage
to the f-cell membrane and induction of DNA strand
breaks, leading to activation of poly (ADP-ribose)
symthetase and NAD depletion [4]
Due to the fact that the experimental animal models
do not exactly resemble the conditions of the human
diabetes, we most verify that the model we select is
the most accurate. So the main objective of this survey
was 10 determine the effect of AL and STZ on the
Langerhans’ islets of the pancreas of rats and to evaluate
the effects of both drugs on the levels of glucose, insulin,
triglycerides and total cholesterol at different intervals
after an intraperitoneal (.p.) injection
Il, Materials and Methods
94 male Sprague-Dawley rats with an average weight
of 300g were maintained on a 12/12 hours light-dark cycle
with water and food ad libitum. Diabetes was induced by
an ip. injection of alloxan 120mg/ke BW in 1.0m of,
bidestilled water to 27 rats; and by 60mg/kg BW of
streptozotocin in 1.0ml of acetate buffer 0.1M. pH 4.3
to 27 rats.
20 control rats for AL were injected ip. with the same
volume of bidestilled water, and 20 control rats for STZ
were injected ip. with 1.0ml of acetate buffer 0.1M,
pH4.3. Animals were allotted in 9 groups of 3 rats each
for AL and also for STZ. Levels of glucose, insulin, total
cholesterol and triglycerides were determined 30 min, 1, 2,
5, 7,9, 12, 1S and 20